A 12-year-old girl presented with weakness, diplopia, and lethargy after a prodrome of gastroenteritis. Laboratory studies were compatible with a diagnosis of hemolytic uremic syndrome. She developed seizures that were controlled by diphenylhydantoin and valium. In spite of peritoneal dialysis and fresh frozen plasma infusions, she progressed to a left hemiplegia associated with a brain scan finding of decreased blood flow in the right middle cerebral artery perfusion area. A 5 liter whole blood exchange transfusion did not improve the neurological status or low platelet count. Daily plasma exchanges with fresh frozen plasma replacement resulted in normal platelet count within 48 hours and was followed by progressive improvement in neurological status. Platelet agglutinating factor decreased to control levels. A repeat brain scan was normal.
Get full access to this article
View all access options for this article.
References
1.
Rudolfi RL, Bell WRThrombotic thrombocytopenic purpura. Report of 25 cases and review of literature . Medicine1981;60:413-28.
2.
Gonzalo A., Mampase F., Gallego N., Bellas C., Segui J., Ortuño J.Hemolytic uremic syndrome with hypocomplementemia and deposits of IgM and C3 in the involved renal tissue. Clin Nephrol1981;16:193-9.
3.
Bergstein JM , Kuederli U., Bang NUPlasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome. Am J Med1982;73:322-7.
Klein PJ, Bulla M., Newman RA, et al. Thomsen-Friedenreich antigen in haemolytic uraemic syndrome . Lancet1977;2:1024-5.
6.
Koster F., Levin J., Walker L., et al. Hemolytic-uremic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes. N Engl J Med1978 ;298:927-33.
7.
Remuzzi G., Mecca G., Livio M., et al. Prostacyclin generation by cultured endothelial cells in haemolytic-uraemic syndrome. Lancet1980 ;1:656-7.
8.
Defreyn G., Pruesmans W., Machin S., et al. Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effects of prostacyclin infusions. Clin Nephrol1982;18:43-9.
9.
Bloom A., Hannaford PA, Greaves M. et al. Hemolytic uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2. Clin Nephrol1985;23:85-8.
10.
Kelton JG, Moore J., Santos A., et al. The detection of a platelet-agglutination factor in thrombotic thrombocytopenic purpura. Ann Intern Med1984 ;101:589-93.
11.
Monnens L., Van de Meer W., Langenhuysen C., et al. Platelet aggregating factor in the epidemic form of hemolytic uremic syndrome in childhood. Clin Nephrol1985;24:135-7.
12.
Moake JL, Byrnes JJ, Troll JH, et al. Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic uremic syndrome. Blood1984;64:592-8.
13.
Sheth KJ, Swick HM, Haworth N.Neurological involvement in hemolytic-uremic syndrome. Ann Neurol1986;19: 90-3.
14.
Bale JF, Brasler C., Siegler RLCNS manifestations of hemolytic uremic syndrome: relationship to metabolic alterations and prognosis. Am J Dis Child1980; 134:869-72.
15.
Gianantonio CA, Vitacco M., Mendilarzu F., et al. The hemolytic uremic syndrome. Nephron1973;11:174-92.
16.
Rooney JC, Anderson RM, Hopkins IJClinical and pathological aspects of central nervous system involvement in the hemolytic uremic syndrome. Aust Paediatr J1971 ;7:28-33.
17.
Camba L., Al-Hilali MM, Shulji MH, et al. Hemolytic uremic syndrome with renal failure: The effect of plasmapheresis. Hematologica1985;70:341-4.
18.
Beattie TJ, Murphy AV, Willoughby Mcn, et al. Plasmapharesis in the haemolytic-uraemic syndrome in children . BMJ1981;282:1667-8.
19.
Gillor A., Bulla M., Roth B., et al. Plasmapharesis as a therapeutic measure in hemolytic-uremic syndrome in children. Klinische Wochenschr1983;61:363-7.
20.
Misiani R., Appiani AC, Edefonti A., et al. Hemolytic uremic syndrome. Therapeutic effect of plasma infusion . Br Med J1982;285:1304-6.
21.
Lian Ec-Y , Mui Ptk, Siddiqui FA, et al. Inhibition of platelet aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. J Clin Invest1984;73:548-55.
22.
Pisciotta AV , Garthwite JD, Darin J., et al. Treatment of thrombotic thrombocytopenic purpura by exchange transfusion. Am J Hematol1977;3:73-82.
23.
Taft EGThrombotic thrombocytopenic purpura and dose of plasma exchange. Blood1979;54:842-9.
24.
Myers TJ, Wakem CJ, Ball ED, et al. Thrombotic thrombocytopenic purpura: Combined treatment with plasmapharesis and antiplatelet agents. Ann Intern Med1980;92:149-55.
25.
Harkness DR , Byrnes JJ, Lian Ec-Y, et al. Hazards of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA1981;246:1931-3.
26.
Hanna J., Sheth KJ, Gill J., Leichter HEEffect of fresh frozen plasma infusions on the outcome of hemolytic uremic syndrome. Kid Int1987;(Abstract)31:200.
27.
Rizzoni G., Pavanello L., Claris-Appiani A., et al. Treatment of children with hemolytic uremic syndrome with plasma: a multicenter controlled trial. Pediatr Nephrol1987 ;(Abstract)1:C-14.
28.
Loirat C., Sonsino E., Hinglais N., et al. Treatment of hemolytic uremic syndrome with fresh frozen plasma—a prospective trial from the Society of Pediatric Nephrology. Pediatr Nephrol1987;(Abstract)1:C52.
29.
Appiani AC, Eedefonti A., Bettinelli A., et al. The relationship between plasma levels of the factor VIII complex and platelet release products (β-thromboglobulin and platelet factor IV) in children with the hemolytic-uremic syndrome. Clin Nephrol1982;17:195-9.
